CAS 1095382-05-0: CCT-137690
Description:CCT-137690, with the CAS number 1095382-05-0, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is classified as a small molecule inhibitor, specifically targeting certain protein kinases, which play crucial roles in various cellular processes, including cell growth and division. The compound is characterized by its unique molecular structure, which contributes to its specificity and efficacy in inhibiting target enzymes. CCT-137690 has been studied for its potential use in cancer treatment, as it may disrupt signaling pathways that are often dysregulated in tumor cells. Additionally, its pharmacokinetic properties, such as solubility and bioavailability, are important for determining its suitability for clinical use. As with many investigational compounds, ongoing research is essential to fully understand its mechanism of action, therapeutic potential, and safety profile.
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | CCT 137690 REF: IN-DA008TEZCAS: 1095382-05-0 | 98% | To inquire | Mon 03 Mar 25 |
 | CCT 137690 REF: TM-T2611CAS: 1095382-05-0 | 98.51% - 99.82% | To inquire | Mon 10 Mar 25 |
 | CCT137690 REF: 3D-VTB38205CAS: 1095382-05-0 | Min. 95% | 348.00 €~1,777.00 € | Mon 14 Apr 25 |
CCT 137690
Ref: IN-DA008TEZ
| 1mg | 60.00 € | ||
| 5mg | 142.00 € | ||
| 25mg | 563.00 € | ||
| 50mg | 635.00 € | ||
| 100mg | To inquire | ||
| 250mg | To inquire |
CCT 137690
- Inhibitors
- Apoptosis
- Cell Cycle/Checkpoint
- Chromatin/Epigenetics
- See more categories
- Aurora Kinase
Ref: TM-T2611
| 2mg | 56.00 € | ||
| 5mg | 79.00 € | ||
| 10mg | 92.00 € | ||
| 25mg | 172.00 € | ||
| 50mg | 311.00 € | ||
| 100mg | 485.00 € | ||
| 1mL*10mM (DMSO) | 95.00 € |
CCT137690
Ref: 3D-VTB38205
| 5mg | 348.00 € | ||
| 10mg | 464.00 € | ||
| 25mg | 738.00 € | ||
| 50mg | 1,111.00 € | ||
| 100mg | 1,777.00 € |
